Summary

Bioniche Life Sciences, Inc. (BNC) SWOT Profile is a comprehensive business, functional and strategic analysis of Bioniche Life Sciences, Inc.. The profile delves into the operations of the company to present an in-depth analysis of the various aspects related to its business. It analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, executive biographies and key competitors. The hallmark of the profile is the detailed strategic analysis of the company. This highlights and presents an unbiased view of its key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by understanding your partners, customers and competitors better.

Bioniche Life Sciences Inc. (Bioniche) is a research-based Canadian pharmacological company engaged on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets globally. The company targets development of its prodcuts in the areas like development of effective therapies for bladder cancer and other cancers; development of a cattle vaccine for prevention of E.


Key Recent Developments

Apr 20, 2010: Bioniche Gets FedDev Ontario Investment To Support New Vaccine Manufacturing Centre
Feb 12, 2010: Bioniche Reaches Additional Milestones In Licensing Agreement With Endo
Jul 10, 2009: Bioniche, Endo Pharmaceuticals Sign Licensing Agreement For Urocidin


Scope

- Examines key information about company for business intelligence.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented objectively. Business, strategic and operational aspects are taken into account.
- Opportunities available to the company are sized up and its growth potential assessed. Competitive and/or technological threats are highlighted.
- The profile contains valuable and critical company information – business structure and operations, the company history, major products and services, prospects, key competitors, key employees, executive biographies, important locations and subsidiaries.
- The profile provides detailed financial ratios for the past five years as well as interim ratios for the last five interim periods for major public companies.
- Financial ratios presented for major public companies include revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Note: Some of the elements mentioned above will be included in the profile based on the availability of information.


Reasons to Buy

- A quick “one-stop-shop” to understand the company clearly.
- Get detailed and exhaustive information and operational & strategic analysis on companies operating in your industry.
- Enhance business/sales activities by understanding customers’ businesses better.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Understand and respond to your competitors’ business structure, strategies, and explore weaknesses.
- With key historical ratios, compare your company’s financial trends with those of your competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably."